20 (S) -Ginsenoside Rg3
Product Specifications
CAS Number
14197-60-5
Target
Endogenous Metabolite, Sodium Channel, NF-κB, Potassium Channel, Beta Amyloid, COX, EGFR
Related Pathways
NF-κB, Immunology/Inflammation, Membrane transporter/Ion channel, JAK/STAT signaling, Neuroscience, Angiogenesis, Tyrosine Kinase/Adaptors, Metabolism
Purity
>99.99%
Bioactivity
20 (S) -Ginsenoside Rg3 (Rg3) possess an ability to inhibit the lung metastasis of tumor cells via inhibition of the adhesion and invasion of tumor cells. It inhibits the proliferation of human umbilical vein endothelial cells (HUVEC) and has anti-angiogenesis activities.
Smiles
CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C
Molecular Formula
C42H72O13
Molecular Weight
785.01
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15158052 1 Vial
Lentiviral human CDH13 shRNA (UAS) - Lentiviral human CDH13 shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details 